WO2011141935A3 - Soft capsular preparation of artemether and lumefantrine and process to manufacture same - Google Patents

Soft capsular preparation of artemether and lumefantrine and process to manufacture same Download PDF

Info

Publication number
WO2011141935A3
WO2011141935A3 PCT/IN2011/000333 IN2011000333W WO2011141935A3 WO 2011141935 A3 WO2011141935 A3 WO 2011141935A3 IN 2011000333 W IN2011000333 W IN 2011000333W WO 2011141935 A3 WO2011141935 A3 WO 2011141935A3
Authority
WO
WIPO (PCT)
Prior art keywords
lumefantrine
artemether
same
capsular preparation
soft capsular
Prior art date
Application number
PCT/IN2011/000333
Other languages
French (fr)
Other versions
WO2011141935A2 (en
Inventor
Jagadindu Chaudhuri Joyendu
Original Assignee
Gujarat Liqui Pharmacaps Pvt. Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gujarat Liqui Pharmacaps Pvt. Ltd filed Critical Gujarat Liqui Pharmacaps Pvt. Ltd
Publication of WO2011141935A2 publication Critical patent/WO2011141935A2/en
Publication of WO2011141935A3 publication Critical patent/WO2011141935A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Abstract

The present invention relates to a soft capsular medicament preparation comprising Artemether 3 to 10 % w/w, Lumefantrine 30 to 60 % w/w, non-aqueous vehicle 17 to 30 % w/w, preservative less than 1 % w/w, viscosity imparting agent 15 to 30 % w/w, suspending agent 1 to 7 % w/w and emulsifying agent 0.7 to 4 % w/w and the method of manufacturing the same and a process to manufacture the same.
PCT/IN2011/000333 2010-05-12 2011-05-12 Soft capsular preparation of artemether and lumefantrine and process to manufacture same WO2011141935A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1498/MUM/2010 2010-05-12
IN1498MU2010 2010-05-12

Publications (2)

Publication Number Publication Date
WO2011141935A2 WO2011141935A2 (en) 2011-11-17
WO2011141935A3 true WO2011141935A3 (en) 2016-05-26

Family

ID=44914777

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2011/000333 WO2011141935A2 (en) 2010-05-12 2011-05-12 Soft capsular preparation of artemether and lumefantrine and process to manufacture same

Country Status (1)

Country Link
WO (1) WO2011141935A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201414918D0 (en) * 2014-08-21 2014-10-08 Corbitt Terence Simon Formulations for transmucosal delivery

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040001005A1 (en) * 2002-06-27 2004-01-01 Lee Chun Liang Method and device for showing conditions of a computer-related apparatus
US20080103192A1 (en) * 2006-10-13 2008-05-01 Washington, University Of Conjugates of artemisinin-related endoperoxides and hydrazone derivatives for the treatment of cancer
US20080160077A1 (en) * 2006-11-27 2008-07-03 Zymes, Llc Soft Gel Formulations
US20090001032A1 (en) * 2007-06-29 2009-01-01 Davison Peter A Higher performance barrier materials for containers of environmentally sensitive semiconductor fabrication devices

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040001005A1 (en) * 2002-06-27 2004-01-01 Lee Chun Liang Method and device for showing conditions of a computer-related apparatus
US20080103192A1 (en) * 2006-10-13 2008-05-01 Washington, University Of Conjugates of artemisinin-related endoperoxides and hydrazone derivatives for the treatment of cancer
US20080160077A1 (en) * 2006-11-27 2008-07-03 Zymes, Llc Soft Gel Formulations
US20090001032A1 (en) * 2007-06-29 2009-01-01 Davison Peter A Higher performance barrier materials for containers of environmentally sensitive semiconductor fabrication devices

Also Published As

Publication number Publication date
WO2011141935A2 (en) 2011-11-17

Similar Documents

Publication Publication Date Title
EP2581098A3 (en) Customised composition and uses thereof
PH12015500561A1 (en) Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
EP2663593B8 (en) Polymer compositions, method of manufacture, and articles formed therefrom
WO2013033438A3 (en) Nanoparticle peg modification with h-phosphonates
WO2011110894A3 (en) A fluid composition comprising a hyaluronan polymer and mannitol for improving skin condition
BR112013025862A2 (en) lignin compositions, methods of producing the compositions, methods of using lignin compositions and products thereby produced
WO2012166923A3 (en) Drug loaded polymeric nanoparticles and methods of making and using same
WO2010115552A8 (en) Bispecific anti-erbb-3/anti-c-met antibodies
WO2011068846A3 (en) Modified rubber compositions and methods of preparation
WO2012056321A3 (en) Bulk enteric capsule shells
HK1187838A1 (en) Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same
EP2658919A4 (en) Thermoplastic vulcanizate composition, method of producing the same, and articles made therefrom
EP2663592B8 (en) Polymer compositions, method of manufacture, and articles formed therefrom
WO2011031849A3 (en) Anionic lipids and lipid nanostructures and methods of producing and using same
WO2011117634A3 (en) Confectionery product containing active and/or reactive components and methods of production thereof
WO2012119780A3 (en) Novel lipids and novel phospholipids structures
WO2012154942A3 (en) Ceramide anionic liposome compositions
WO2012050393A3 (en) Novel compound of a reverse-turn mimetic and a production method and use therefor
WO2013164839A3 (en) Amorphous form of apixaban, process of preparation and compositions thereof
WO2012017323A3 (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by hiv or associated with hiv
WO2012051117A3 (en) Substituted benzamides and their uses
WO2012142292A3 (en) Biofunctionalized polymer microparticles for biotherapeutic delivery and processes for using and making the same
EP3722277A3 (en) 3'end caps for rna-interferring agents for use in rna
WO2012086964A3 (en) Amphiphilic cyclic phosphazene trimer, hydrophobic pharmaceutical formulation micellized by amphiphilic cyclic phosphazene trimer, and preparation methods thereof
WO2011140312A3 (en) Method of making an aerosol shave composition comprising a hydrophobical agent forming at least one microdroplet

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11780316

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11780316

Country of ref document: EP

Kind code of ref document: A2